For ALS, the pioneering study by Wang et al. showed that intraperitoneal injection of DPSC secretome in an ALS mouse model expressing the ALS-causing mutation G93A in superoxide dismutase 1 (SOD1G93A) increased lifespan and the number of surviving motoneurons [29]. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.